ResMed Inc.
Health
Performance
5.6
Risk
Sell
Buy
Curious about the Scores? Learn more.

ResMed Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

02.07.2026
Signs of control returning. Still shaky, but not chaos.
26.05.2026
Fragile setup. Still failing to meet the key marks today.
23.03.2026
Momentum tanked. Clearly underperforming.
20.08.2025
Back in top shape. Balance sheet solid, outlook sharp.
RMD
ResMed Inc.
198.61
-0.19%
5.6
Sell
Buy
ResMed Inc.

ResMed Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does ResMed Inc. do? Business model and key facts

Get the full picture of ResMed Inc.: what it builds, where it operates, and how it makes money.

ResMed Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 10600

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

shop
Company facts
Michael J. Farrell
CEO
10600
Employees worldwide
shop
Performance
-23.92%
Last 12 months
-22.19%
Last 5 years
shop
Growth
$5.15B
Revenue year
$1.40B
Net income
shop
Valuation
$28.86B
Market Cap
27.02
Price/Earnings Ratio

Stocks related to ResMed Inc.

Selected based on industry alignment and relative market positioning.

DXCM
DexCom, Inc.
75.69
-1.25%
6.1
Sell
Buy
DexCom, Inc.
EW
Edwards Lifesciences Corporation
85.00
-0.85%
2.7
Sell
Buy
Edwards Lifesciences Corporation
BSX
Low-poly 3D Boston Scientific (BSX) stock icon with a stylized medical symbol, symbolizing healthcare and biotech.
43.77
-0.59%
7.1
Sell
Buy
Boston Scientific Corporation
ZBH
Zimmer Biomet Holdings, Inc.
89.72
-1.54%
3.5
Sell
Buy
Zimmer Biomet Holdings, Inc.
SNN
Smith & Nephew plc
30.43
-0.52%
3.2
Sell
Buy
Smith & Nephew plc

Events and news impacting ResMed Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

ResMed Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.